Skip to main content
Fig. 1 | BMC Neurology

Fig. 1

From: BRAFnon-V600E more frequently co-occurs with IDH1/2 mutations in adult patients with gliomas than in patients harboring BRAFV600E but without a survival advantage

Fig. 1

The scheme of the enrollment and investigation of data. In all 20 CNS/Brain studies, including 6164 samples, 90 patients with BRAFV600E or BRAFnon-V600E were enrolled; 52 nonredundant patients displayed major patient characteristics, including sex, age, cancer type detailed, co-occurring mutations, and copy number alteration genes, and were enrolled for further analysis

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us